BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10390532)

  • 1. Plasmid linking number change induced by topoisomerase I-mediated DNA damage.
    Duann P; Sun M; Lin CT; Zhang H; Liu LF
    Nucleic Acids Res; 1999 Jul; 27(14):2905-11. PubMed ID: 10390532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid chromatin reorganization induced by topoisomerase I-mediated DNA damage.
    Sun M; Duann P; Lin CT; Zhang H; Liu LF
    Ann N Y Acad Sci; 2000; 922():340-2. PubMed ID: 11193917
    [No Abstract]   [Full Text] [Related]  

  • 3. Enhanced CPT sensitivity of yeast cells and selective relaxation of Ga14 motif-containing DNA by novel Gal4-topoisomerase I fusion proteins.
    Alessandri M; Beretta GL; Ferretti E; Mancia A; Khobta A; Capranico G
    J Mol Biol; 2004 Mar; 337(2):295-305. PubMed ID: 15003448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A gel electrophoresis assay for the simultaneous determination of topoisomerase I inhibition and DNA intercalation.
    Webb MR; Ebeler SE
    Anal Biochem; 2003 Oct; 321(1):22-30. PubMed ID: 12963051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of topoisomerase I or II may lead to recombination or to aberrant replication termination on both SV40 and yeast 2 micron DNA.
    Levac P; Moss T
    Chromosoma; 1996 Oct; 105(4):250-60. PubMed ID: 8854885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-Molecule Supercoil Relaxation Assay as a Screening Tool to Determine the Mechanism and Efficacy of Human Topoisomerase IB Inhibitors.
    Seol Y; Zhang H; Agama K; Lorence N; Pommier Y; Neuman KC
    Mol Cancer Ther; 2015 Nov; 14(11):2552-9. PubMed ID: 26351326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assays for the preferential binding of human topoisomerase I to supercoiled DNA.
    Yang Z; Champoux JJ
    Methods Mol Biol; 2009; 582():49-57. PubMed ID: 19763941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topoisomerase I interaction with SV40 DNA in the presence and absence of camptothecin.
    Jaxel C; Kohn KW; Pommier Y
    Nucleic Acids Res; 1988 Dec; 16(23):11157-70. PubMed ID: 2849758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Camptothecin enhances random integration of transfected DNA into the genome of mammalian cells.
    Shcherbakova OG; Filatov MV
    Biochim Biophys Acta; 2000 Jan; 1495(1):1-3. PubMed ID: 10634926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topological analysis of plasmid chromatin from yeast and mammalian cells.
    Tong W; Kulaeva OI; Clark DJ; Lutter LC
    J Mol Biol; 2006 Sep; 361(5):813-22. PubMed ID: 16890953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Supercoiling in prokaryotic and eukaryotic DNA: changes in response to topological perturbation of plasmids in E. coli and SV40 in vitro, in nuclei and in CV-1 cells.
    Esposito F; Sinden RR
    Nucleic Acids Res; 1987 Jul; 15(13):5105-24. PubMed ID: 3037487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tryptophane-205 of human topoisomerase I is essential for camptothecin inhibition of negative but not positive supercoil removal.
    Frøhlich RF; Veigaard C; Andersen FF; McClendon AK; Gentry AC; Andersen AH; Osheroff N; Stevnsner T; Knudsen BR
    Nucleic Acids Res; 2007; 35(18):6170-80. PubMed ID: 17827209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA supercoiling of recombinant plasmids in mammalian cells.
    Shen CK; Hu WS
    Proc Natl Acad Sci U S A; 1986 Mar; 83(6):1641-5. PubMed ID: 3006061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA-unwinding test using eukaryotic DNA topoisomerase I.
    Shen LL
    Methods Mol Biol; 2001; 95():149-60. PubMed ID: 11089228
    [No Abstract]   [Full Text] [Related]  

  • 15. Characterization of a mammalian mutant with a camptothecin-resistant DNA topoisomerase I.
    Andoh T; Ishii K; Suzuki Y; Ikegami Y; Kusunoki Y; Takemoto Y; Okada K
    Proc Natl Acad Sci U S A; 1987 Aug; 84(16):5565-9. PubMed ID: 3039492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a novel topoisomerase I mutation from a camptothecin-resistant human prostate cancer cell line.
    Urasaki Y; Laco GS; Pourquier P; Takebayashi Y; Kohlhagen G; Gioffre C; Zhang H; Chatterjee D; Pantazis P; Pommier Y
    Cancer Res; 2001 Mar; 61(5):1964-9. PubMed ID: 11280753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Template supercoiling during ATP-dependent DNA helix tracking: studies with simian virus 40 large tumor antigen.
    Yang L; Jessee CB; Lau K; Zhang H; Liu LF
    Proc Natl Acad Sci U S A; 1989 Aug; 86(16):6121-5. PubMed ID: 2548199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo sequencing of camptothecin-induced topoisomerase I cleavage sites in human colon carcinoma cells.
    Pondarré C; Strumberg D; Fujimori A; Torres-León R; Pommier Y
    Nucleic Acids Res; 1997 Oct; 25(20):4111-6. PubMed ID: 9321666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Directed evolution to increase camptothecin sensitivity of human DNA topoisomerase I.
    Scaldaferro S; Tinelli S; Borgnetto ME; Azzini A; Capranico G
    Chem Biol; 2001 Sep; 8(9):871-81. PubMed ID: 11564555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of DNA topology on plasmid DNA repair in vivo.
    Park JY; Ahn B
    FEBS Lett; 2000 Jul; 476(3):174-8. PubMed ID: 10913608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.